Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 825,936
- Share change
- -7,866
- Total reported value
- $2,049,754
- Price per share
- $2.49
- Number of holders
- 2
- Value change
- -$20,365
- Number of buys
- 1
- Number of sells
- 1
Report period
Q4 2023
Institutions
2
Top holders
2
OCX full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C107
Recent filing periods:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
7.8%
|
2,509,066
|
$7,828,286 | — | 30 Sep 2023 | |
| AWM Investment Company, Inc. |
13F
|
Company |
2.5%
|
719,282
|
$2,359,245 | — | 30 Sep 2023 | |
| PURA VIDA INVESTMENTS, LLC |
3/4/5
13F
|
10%+ Owner · Company |
2%
from 13F
|
16,591,052
mixed-class rows
|
$3,044,309 | — | 14 Apr 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.74%
|
240,089
|
$749,078 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
139,538
|
$435,359 | — | 30 Sep 2023 | |
| Defender Capital, LLC. |
13F
|
Company |
0.4%
|
114,520
|
$357,302 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
61,482
|
$201,727 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.19%
|
60,293
|
$188,114 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
16,289
|
$53,428 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
14,754
|
$48,393 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
12,218
|
$38,000 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,556
|
$7,975 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,266
|
$3,950 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,025
|
$3,198 | — | 30 Sep 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,019
|
$3,000 | — | 30 Sep 2023 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
500
|
$1,560 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
210
|
$655 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
154
|
$505 | — | 30 Sep 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
66
|
$216 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
58
|
$181 | — | 30 Sep 2023 | |
| Riggs Asset Managment Co. Inc. |
13F
|
Company |
0%
|
50
|
$156 | — | 30 Sep 2023 | |
| COMERICA BANK |
13F
|
Company |
0%
|
37
|
$116 | — | 30 Sep 2023 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
25
|
$78 | — | 30 Sep 2023 | |
| Piscataqua Savings Bank |
13F
|
Company |
0%
|
25
|
$77 | — | 30 Sep 2023 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
9
|
$28 | — | 30 Sep 2023 | |
| ALBION FINANCIAL GROUP /UT |
13F
|
Company |
0%
|
7
|
$22 | — | 30 Sep 2023 | |
| Lindbrook Capital, LLC |
13F
|
Company |
0%
|
4
|
$12 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Sep 2023 | |
| John Peter Gutfreund |
3/4/5
|
Former Director |
—
mixed-class rows
|
760,000
mixed-class rows
|
$153,654 | — | 30 Jun 2023 | |
| Ronald Asbury Andrews |
3/4/5
|
Former CEO, Director |
—
mixed-class rows
|
633,212
mixed-class rows
|
$125,332 | — | 01 Dec 2022 | |
| Alfred D. Kingsley |
3/4/5
|
Director |
—
mixed-class rows
|
597,878
mixed-class rows
|
$109,143 | — | 23 Jun 2023 | |
| Gisela Paulsen |
3/4/5
|
Former President and COO |
—
class O/S missing
|
366,500
|
$78,761 | — | 16 Dec 2022 | |
| Li Yu |
3/4/5
|
VP Cntrllr/Prncpl Acctng Offcr |
—
mixed-class rows
|
41,872
mixed-class rows
|
$76,536 | — | 18 May 2022 | |
| Ross Douglas T. |
3/4/5
|
Former CSO |
—
class O/S missing
|
234,114
|
$50,311 | — | 21 Dec 2022 | |
| Cavan M. Redmond |
3/4/5
|
Director |
—
class O/S missing
|
120,863
|
$25,973 | — | 24 Jun 2022 | |
| Mitchell S. Levine |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
174,580
mixed-class rows
|
$18,713 | — | 15 Mar 2022 | |
| Jennifer Levin Carter |
3/4/5
|
Director |
—
mixed-class rows
|
75,500
mixed-class rows
|
$6,554 | — | 15 Aug 2022 | |
| Melinda Griffith |
3/4/5
|
Director |
—
mixed-class rows
|
75,000
mixed-class rows
|
$6,447 | — | 15 Aug 2022 | |
| Anish M. John |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
121,381
|
— | — | 24 Feb 2023 | |
| Padmavathi Sundar |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
87,500
|
— | — | 15 Mar 2022 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q4 2023
As of 31 Dec 2023,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
825,936 shares.
The largest 2 holders included
AWM Investment Company, Inc. and Defender Capital, LLC..
This page lists
2
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
2
Q4 2023 holders
2
Holder diff
0
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.